Phenytoin for motion sickness: Clinical evaluation
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Phenytoin has previously been shown to protect against motion sickness induced by Coriolis stimulation. The purpose of our series of investigations was to investigate further the efficacy of phenytoin for motion sickness prophylaxis and to gain insight into its mechanism of action. We tested participants with electronystagmography, off‐vertical rotation, sea travel, and parabolic flight after they received phenytoin or placebo. Blood levels of at least 9 μg/mL were found to protect against motion sickness. Electronystagmography showed significant decreases in the gain of the vestibuloocular reflex in participants receiving phenytoin. Few side effects were seen with drug levels in the 9 to 15 μg/mL range. Phenytoin is an effective motion sickness countermeasure that may exert its effect through a combination of central nervous system and peripheral vestibular effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuroleptics including barbiturates, diazepam, and baclofen as well as phenytoin were found to be effective in prevention of MS [114-118] (Table 2).”
From Motion Sickness: Current Knowledge and Recent Advance. (2016) · cites this paper as [118]
In the citing paper
“| Phenytoin | p.o. (200 mg) | 4 h before MS | Seasickness and parabolic flight MS | [117,118] |”
From Motion Sickness: Current Knowledge and Recent Advance. (2016) · cites this paper as [118]
Citations
Cites
Basic Mechanisms of the Epilepsies.
(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-969_2 · Cited by 1,105
Experimental Determination of the Anticonvulsant Properties of Some Phenyl Derivatives
Putnam, T. J., & Merritt, H. H. (1937) · Science · doi:10.1126/science.85.2213.525 · Cited by 306
Crampton, G. H. (1990) · Medical Entomology and Zoology · Cited by 273
Kennedy, R. S., Graybiel, A., McDonough, R. C., & Beckwith, D. (1968) · Acta Oto-Laryngologica · doi:10.3109/00016486809126317 · Cited by 99
Julien, R. M., & Halpern, L. M. (1972) · Epilepsia · doi:10.1111/j.1528-1157.1972.tb04579.x · Cited by 82
Uijtdehaage, S. H. J., Stern, R. M., & Koch, K. L. (1992) · Psychophysiology · doi:10.1111/j.1469-8986.1992.tb01685.x · Cited by 76
Neuropharmacology and neurochemistry of anticonvulsant drugs.
Dm, W., & Esplin, D. W. (1959) · PubMed · Cited by 69
Effect of Dilantin and Mesantoin on the Giant Axon of the Squid.
Korey, S. R. (1951) · Experimental Biology and Medicine · doi:10.3181/00379727-76-18469 · Cited by 63
(1993) · PubMed · Cited by 54
NEUROPHARMACOLOGY OF PERIPHERAL NERVE
Toman, J. E. P. (1952) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07320-x · Cited by 48
Research works printed but not linked: 13
- Beeson P. B., 1979, Textbook of Medicine, 851
- Chinn H. I., 1955, Motion Sickness, Pharmacol Rev, 7, 33
- Dhenin G., 1978, Aviation Medicine
- Chelen W., 1991, Electroencephalographs Spectral Changes During Motion Sickness, Aviat Space Environ Med, 63, 462
- Chelen W., 1993, Spectral Analysis of the Electroencephalographs Response to Motion Sickness, Aviat Space Environ Med, 64, 24
- DeLorenzo R. J., 1989, Antiepileptic Drugs, 143
- Woodbury D. M., 1955, Effect of Diphenylhydantoin on Electrolytes and on Sodium Turnover in Brain and Other Tissues of Normal, Hyponatremic and Postictal Rats, J Pharmacol Exp Ther, 115, 74
- Woodbury D. M., 1982, Antiepileptic Drugs, 269
- Woodbury D. M., 1972, Antiepileptic Drugs, 113
- Delgado‐Escueta A. V., 1986, Advances in Neurology, 3
- Mameli O., 1982, Vestibular Disturbances During Antiepileptic Drug Treatment, Studi Sassaresi, 60, 117
- Shin I. J., 1988, The Effect of Nontoxic Levels of Phenytoin on Brainstem Auditory Evoked Potentials in Normal Subjects, Neurology, 38, 337
- Reason J. T., 1975, Motion Sickness, 63
Cited by
Motion Sickness: Current Knowledge and Recent Advance.
Zhang, L., Wang, J., Qi, R., Pan, L., Li, M., & Cai, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12468 · Cited by 216
Neuropharmacology of Vestibular System Disorders
Soto, E., & Vega, R. (2010) · Current Neuropharmacology · doi:10.2174/157015910790909511 · Cited by 140
Neuropharmacological basis of vestibular system disorder treatment
Soto, E., Vega, R., & Seseña, E. (2013) · Journal of Vestibular Research · doi:10.3233/ves-130494 · Cited by 60
Pharmacologic Treatment of Persons with Dizziness
Hain, T. C., & Yacovino, D. A. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2005.01.012 · Cited by 57
“A sodium channel blocker, phenytoin (Dilantin), is reported to protect against motion sickness two times more effectively than the combination of scopolamine and dextroamphetamine [69,70].”
BackgroundPharmacology of Motion Sickness
Lucot, J. B. (1998) · Journal of Vestibular Research · doi:10.3233/ves-1998-8109 · Cited by 26
Metadata
- Authors
- Knox, G. W., Woodard, D., Chelen, W., Ferguson, R., & Johnson, L.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Knox, Glenn W.
- Venue
- The Laryngoscope
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 104
- Issue
- 8
- Pages
- 935-939
- ISSN
- 0023-852X (ISSN-L)
- 1531-4995
- OpenAlex
- W1980090640
- Cited by
- 19
- References
- 34
- Citations by year
- 2023: 2 · 2022: 1 · 2018: 1 · 2015: 1 · 2013: 3 · 2012: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Laryngoscope (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Health Sciences › Medicine › Physiology (medical) › Spaceflight effects on biology
- Keywords
- phenytoin, motion sickness, vestibulo-ocular reflex, electronystagmography, maritime travel, parabolic flight, blood drug levels, central nervous system effects
- MeSH terms
- Adult, Aerospace Medicine, Caloric Tests, Double-Blind Method, Electronystagmography, Humans, Middle Aged, Motion Sickness, Nausea, Oceans and Seas, Phenytoin, Placebos, Reflex, Vestibulo-Ocular, Rotation, Time Factors, Travel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenytoin for motion sickness: Clinical evaluation. https://app.cochat.ai/papers/10.1288/00005537-199408000-00005
- The paper
- Knox, G. W., Woodard, D., Chelen, W., Ferguson, R., & Johnson, L. (1994). Phenytoin for motion sickness: Clinical evaluation. The Laryngoscope. https://doi.org/10.1288/00005537-199408000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.